Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.

Khera, Nandita; Edwards, Marie Louise; Song, Yan; Sun, Rochelle; Manghani, Rocio; Shin, Heayoung; Simantov, Ronit; Signorovitch, James; Sivaraman, Smitha; Gergis, Usama

Khera, Nandita; Edwards, Marie Louise; Song, Yan; Sun, Rochelle; Manghani, Rocio; Shin, Heayoung; Simantov, Ronit; Signorovitch, James; Sivaraman, Smitha; Gergis, Usama.

Afiliación

Khera N; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
Edwards ML; Analysis Group Inc., New York, NY, USA.
Song Y; Analysis Group Inc., Boston, MA, USA.
Sun R; Analysis Group Inc., Boston, MA, USA.
Manghani R; Gamida Cell Inc., Boston, MA, USA.
Shin H; Gamida Cell Inc., Boston, MA, USA.
Simantov R; Gamida Cell Inc., Boston, MA, USA.
Signorovitch J; Analysis Group Inc., Boston, MA, USA.
Sivaraman S; Gamida Cell Inc., Boston, MA, USA.
Gergis U; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu.

Adv Ther ; 41(7): 3013, 2024 Jul.

Article en En | MEDLINE | ID: mdl-38762585

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google